Chan KKW - Search Results

1

Assessing the efficacy-effectiveness gap for cancer therapies: A comparison of overall survival and toxicity between clinical trial and population-based, real-world data for contemporary parenteral cancer therapeutics.

Phillips CM, Parmar A, Guo H, Schwartz D, Isaranuwatchai W, Beca J, Dai W, Arias J, Gavura S, Chan KKW. Phillips CM, et al. Among authors: chan kkw. Cancer. 2020 Apr 15;126(8):1717-1726. doi: 10.1002/cncr.32697. Epub 2020 Jan 8. Cancer. 2020. PMID: 31913522 Free article.

2

Early mortality and overall survival in oncology phase I trial participants: can we improve patient selection?

Chau NG, Florescu A, Chan KK, Wang L, Chen EX, Bedard P, Oza AM, Siu LL. Chau NG, et al. BMC Cancer. 2011 Oct 5;11:426. doi: 10.1186/1471-2407-11-426. BMC Cancer. 2011. PMID: 21975023 Free PMC article.

3

Low-dose metronomic chemotherapy: a systematic literature analysis.

Lien K, Georgsdottir S, Sivanathan L, Chan K, Emmenegger U. Lien K, et al. Eur J Cancer. 2013 Nov;49(16):3387-95. doi: 10.1016/j.ejca.2013.06.038. Epub 2013 Jul 20. Eur J Cancer. 2013. PMID: 23880474 Review.

4

Efficacy and safety of palonosetron for the prophylaxis of chemotherapy-induced nausea and vomiting (CINV): a systematic review and meta-analysis of randomized controlled trials.

Popovic M, Warr DG, Deangelis C, Tsao M, Chan KK, Poon M, Yip C, Pulenzas N, Lam H, Zhang L, Chow E. Popovic M, et al. Support Care Cancer. 2014 Jun;22(6):1685-97. doi: 10.1007/s00520-014-2175-6. Epub 2014 Mar 4. Support Care Cancer. 2014. PMID: 24590374 Review.

5

Genomic testing in cancer: patient knowledge, attitudes, and expectations.

Blanchette PS, Spreafico A, Miller FA, Chan K, Bytautas J, Kang S, Bedard PL, Eisen A, Potanina L, Holland J, Kamel-Reid S, McPherson JD, Razak AR, Siu LL. Blanchette PS, et al. Cancer. 2014 Oct 1;120(19):3066-73. doi: 10.1002/cncr.28807. Epub 2014 Jun 24. Cancer. 2014. PMID: 24962202 Free article.

6

Continuous versus intermittent chemotherapy strategies in metastatic colorectal cancer: a systematic review and meta-analysis.

Berry SR, Cosby R, Asmis T, Chan K, Hammad N, Krzyzanowska MK; Cancer Care Ontario's Gastrointestinal Disease Site Group. Berry SR, et al. Ann Oncol. 2015 Mar;26(3):477-85. doi: 10.1093/annonc/mdu272. Epub 2014 Jul 23. Ann Oncol. 2015. PMID: 25057174 Free article. Review.

7

Cost-effectiveness of prophylactic granulocyte colony-stimulating factor for febrile neutropenia in breast cancer patients receiving FEC-D.

Lee EK, Wong WW, Trudeau ME, Chan KK. Lee EK, et al. Breast Cancer Res Treat. 2015 Feb;150(1):169-80. doi: 10.1007/s10549-015-3309-3. Epub 2015 Feb 19. Breast Cancer Res Treat. 2015. PMID: 25694355

8

Frontline rituximab monotherapy induction versus a watch and wait approach for asymptomatic advanced-stage follicular lymphoma: A cost-effectiveness analysis.

Prica A, Chan K, Cheung M. Prica A, et al. Cancer. 2015 Aug 1;121(15):2637-45. doi: 10.1002/cncr.29372. Epub 2015 Apr 15. Cancer. 2015. PMID: 25877511 Free article.

9

Adjuvant taxane-based chemotherapy for early stage breast cancer: a real-world comparison of chemotherapy regimens in Ontario.

Torres S, Trudeau M, Eisen A, Earle CC, Chan KKW. Torres S, et al. Among authors: chan kkw. Breast Cancer Res Treat. 2015 Jul;152(1):137-145. doi: 10.1007/s10549-015-3441-0. Epub 2015 May 31. Breast Cancer Res Treat. 2015. PMID: 26026467

10

Chemoradiotherapy regimens for locoregionally advanced nasopharyngeal carcinoma: A Bayesian network meta-analysis.

Yan M, Kumachev A, Siu LL, Chan KK. Yan M, et al. Eur J Cancer. 2015 Aug;51(12):1570-9. doi: 10.1016/j.ejca.2015.04.027. Epub 2015 Jun 1. Eur J Cancer. 2015. PMID: 26044925 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

323 results

Search Page